In conclusion, this study first elucidates the oncogenic role of hypomethylation- and hypermethylation-mediated regulation of CYSLTR1 and CYSLTR2 expression in CRC, respectively. This evidence concerns the gene CYSLTR2 and colorectal carcinoma.